ABX-EGF
| ABX-EGF | |
|---|---|
| Term | ABX-EGF |
| Short definition | ABX-EGF - A medicine used alone or with other medicines to treat certain types of colon cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated or whose cancer has gotten worse after treatment with other anticancer medicines. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ABX-EGF - A medicine used alone or with other medicines to treat certain types of colon cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated or whose cancer has gotten worse after treatment with other anticancer medicines. It is also being studied in the treatment of other types of cancer. ABX-EGF attaches to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein can help prevent cancer cells from growing. ABX-EGF is a type of monoclonal antibody. Also called panitumumab and vectibix
External links
- Medical encyclopedia article on ABX-EGF
- Wikipedia's article - ABX-EGF
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski